Printer Friendly
The Free Library
19,585,950 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Abiomed to Present at 9th Annual Needham and Company Growth Conference.


DANVERS, Mass. -- Abiomed, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: ABMD ABMD areal bone mineral density
ABMD AEGIS Ballistic Missile Defense (US Navy)
ABMD Advanced Ballistic Missile Defense
) announced today that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the 9th Annual Needham and Company Growth Conference on January 11, 2007 at 9:30 a.m. ET. The conference will be held at the New York Palace
  • Palace Theatre, New York
  • New York Palace, Budapest, Hungary
 Hotel in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
.

ABOUT ABIOMED

Based in Danvers, Massachusetts Danvers is a town in Essex County, Massachusetts, United States. Located on the Danvers River near the northeastern coast of Massachusetts, Danvers is most widely known for its association with the 1692 Salem witch trials. , Abiomed, Inc., is a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart. Abiomed currently manufactures and sells the AB5000[TM] Circulatory Support System and the BVS BVS Biblioteca Virtual em Saúde (Brazil)
BVS Bureau of Vital Statistics
BVS Brethren Volunteer Service (Church of the Brethren)
BVS Boston Vegetarian Society (Cambridge, MA) 
([R]) 5000 Biventricular Support System for the temporary support of all patients with failing but potentially recoverable hearts. The Company also developed the AbioCor([R]) Implantable Replacement Heart. In Europe, Abiomed offers the minimally invasive Impella([R]) Circulatory Support System under CE Mark approval. The Impella([R]) 5.0 and 2.5 are investigational devices limited by Federal Law solely to investigational use in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . Other Impella devices are not yet available for sale in the United States. For additional information please visit: www.abiomed.com.

FORWARD-LOOKING STATEMENTS

This Release contains forward-looking statements, including statements regarding development of Abiomed's existing and new products, the Company's progress toward commercial growth, and future opportunities. The Company's actual results may differ materially from those anticipated in these forward-looking statements based upon a number of factors, including uncertainties associated with development, testing and related regulatory approvals, anticipated future losses, complex manufacturing, high quality requirements, dependence on limited sources of supply, competition, technological change, government regulation, future capital needs and uncertainty of additional financing, and other risks and challenges detailed in the Company's filings with the Securities and Exchange Commission, including the Annual Report filed on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this Release. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this Release or to reflect the occurrence of unanticipated events.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 3, 2007
Words:357
Previous Article:Berklee College of Music Set to Deliver Free Contemporary Music Education to Underserved Youth Nationwide.
Next Article:NDS And CyberLink Join Forces to Securely Deliver TV Entertainment To PCs.
Topics:



Related Articles
ABIOMED to Present at Bank of America Healthcare Conference.
Abiomed to Present at Needham & Company's Fifth Annual Biotechnology and Medical Technology Conference.
Abiomed to Present at Canaccord Adams 26th Annual Summer Seminar 2006.
Abiomed to Present at Thomas Weisel Partners Healthcare Conference 2006.
Abiomed to Present at UBS Global Life Sciences Conference.
Abiomed to Present at Lazard Capital Markets Third Annual Life Sciences Conference.
Abiomed to Present at 2007 JPMorgan Healthcare Conference.
Abiomed Announces Development of Pediatric Circulatory Support Technology.
Abiomed Announces Data on Impella 2.5 for Improved Cardiac Function for Pre-Shock Acute Myocardial Infarction.
Abiomed Announces Schedule of Events for Breakthrough Impella Technology at EuroPCR Conference in Barcelona.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles